GNTA – genenta science s.p.a. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

GNTA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/27

02:47 pm

gnta

Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

11/24

04:00 am

gnta

Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial

Low Report

Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial

Report

11/21

01:59 pm

gnta

Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Medium Report

Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

10/31

01:03 pm

gnta

Genenta Science (NASDAQ:GNTA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

High Report

Genenta Science (NASDAQ:GNTA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Report

10/26

08:30 pm

gnta

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

High Report

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.